Clinical trial
Molecular Metastasis in Lymph Nodes is Associated With Survival of Patients With Stage I NSCLC
NCT04266691 is registered in ClinicalTrials.gov with Zhejiang Cancer Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Metastasis in Lymph Nodes is Associated With Survival of Patients With Stage I NSCLC
- Lead sponsor
- Zhejiang Cancer Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2009
- Completion date
- June 30, 2019
- Enrollment
- 237 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer